Retro Biosciences
Redwood City
About Retro Biosciences
Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics. The company is engaged in cellular reprogramming, autophagy, and developing therapeutics inspired by plasma to combat aging. Retro Biosciences aims to extend healthy human lifespan by 10 years through innovative biotechnology focused on aging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $180.0M
- Funding stage: Seed
- Last round: Angel (Apr 2022)
- Website: retro.bio
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/retro-biosciences-112040 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.